Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05116566 · ClinicalTrials.gov registry record
Revealing Information Genuinely & Honestly Across Time: Pediatric Oncology Stakeholder Preferences and Recommendations for Prognostic Communication
A clinical trial, sponsored by St. Jude Children's Research Hospital.
- Completed
- Registry status
- 95
- Enrollment target
NCT05116566 is a clinical trial that has completed, run by St. Jude Children's Research Hospital. The registered enrollment target is 95 participants.
The verdict
NCT05116566 has completed, sponsored by St. Jude Children's Research Hospital.
- COMPLETED
- Registry status
- 95 participants
- Enrollment target
Study Summary
This study is being conducted to better understand the preferences and recommendations of patients and parents regarding optimal ways to share prognostic communication. Specifically, to learn what stakeholders (i.e., patients, parents, and doctors) believe to be the "right" content, timing, and delivery of this important information. Specific Aim 1 * To define key stakeholder preferences and recommendations for timing, content, and delivery of prognostic communication across the advancing illness course and bereavement. Specific Aim 2 * To engage stakeholders in the design of a patient/parent centered RIGHTime framework and communication intervention to promote individualized, timely prognostic disclosure.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 95 participants |
| Start Date | 2022-06-18 |
| Est. Completion | 2024-08-14 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05116566
The ClinicalTrials.gov registry entry for NCT05116566 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 95 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is St. Jude Children's Research Hospital, which has 410 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 0 interventions.
NCT05116566 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT05116566 about?
NCT05116566 is a clinical study titled "Revealing Information Genuinely & Honestly Across Time: Pediatric Oncology Stakeholder Preferences and Recommendations for Prognostic Communication". This study is being conducted to better understand the preferences and recommendations of patients and parents regarding optimal ways to share prognostic communication. Specifically, to learn what stakeholders (i.e., patients, parents, and doctors) believe to be the "right" content, timing, and deli...
What is the current status of trial NCT05116566?
This trial is currently completed. The enrollment target is 95 participants. The study started on 2022-06-18. Estimated completion is 2024-08-14.
Who is sponsoring clinical trial NCT05116566?
This trial is sponsored by St. Jude Children's Research Hospital, which has 410 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.